Table 2.

Use of bone-active treatment in the 6 months following a fracture^*

	Non-vertebral (n = 6395)	Forearm (n = 1338)	Hip (n = 1072)	Vertebral (n = 1033)
Bisphosphonates	253	51	53	276
	(4.9%)	(4.4%)	(7.2%)	(33.4%)
Hormone replacement therapy	251	59	15	29
	(4.8%)	(5.1%)	(2.0%)	(3.7%)
Vitamin D	96	14	23	42
	(1.8%)	(1.2%)	(3.1%)	(5.3%)
Calcitonin	8	1	1	12
	(0.2%)	(0.1%)	(0.1%)	(1.5%)

^*Patients who died or transferred out within 6 months of the fracture were excluded.